Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

LGND vs OMAB vs PAC vs PRGO vs ASUR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
LGND
Ligand Pharmaceuticals Incorporated

Biotechnology

HealthcareNASDAQ • US
Market Cap$4.13B
5Y Perf.+107.1%
OMAB
Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.

Airlines, Airports & Air Services

IndustrialsNASDAQ • MX
Market Cap$5.16B
5Y Perf.+203.5%
PAC
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.

Airlines, Airports & Air Services

IndustrialsNYSE • MX
Market Cap$10.79B
5Y Perf.+278.4%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%
ASUR
Asure Software, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$263M
5Y Perf.+48.5%

LGND vs OMAB vs PAC vs PRGO vs ASUR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
LGND logoLGND
OMAB logoOMAB
PAC logoPAC
PRGO logoPRGO
ASUR logoASUR
IndustryBiotechnologyAirlines, Airports & Air ServicesAirlines, Airports & Air ServicesDrug Manufacturers - Specialty & GenericSoftware - Application
Market Cap$4.13B$5.16B$10.79B$1.61B$263M
Revenue (TTM)$251M$15.96B$32.53B$4.18B$148M
Net Income (TTM)$49M$5.34B$10.36B$-1.82B$-10M
Gross Margin85.9%75.6%32.6%34.2%67.9%
Operating Margin7.0%56.0%54.0%-4.1%-2.7%
Forward P/E23.6x0.8x1.0x5.6x10.6x
Total Debt$7M$13.59B$46.66B$3.97B$80M
Cash & Equiv.$72M$3.10B$10.45B$532M$25M

LGND vs OMAB vs PAC vs PRGO vs ASURLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

LGND
OMAB
PAC
PRGO
ASUR
StockMay 20May 26Return
Ligand Pharmaceutic… (LGND)100207.1+107.1%
Grupo Aeroportuario… (OMAB)100303.5+203.5%
Grupo Aeroportuario… (PAC)100378.4+278.4%
Perrigo Company plc (PRGO)10021.4-78.6%
Asure Software, Inc. (ASUR)100148.5+48.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: LGND vs OMAB vs PAC vs PRGO vs ASUR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: OMAB leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Ligand Pharmaceuticals Incorporated is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. PAC and PRGO also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
LGND
Ligand Pharmaceuticals Incorporated
The Defensive Pick

LGND is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.

  • Lower volatility, beta 0.99, Low D/E 0.9%, current ratio 8.93x
  • 27.3% revenue growth vs PRGO's -2.8%
  • +99.1% vs PRGO's -51.2%
Best for: sleep-well-at-night
OMAB
Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.
The Value Pick

OMAB carries the broadest edge in this set and is the clearest fit for valuation efficiency and defensive.

  • PEG 0.02 vs PAC's 0.03
  • Beta 0.62, yield 5.0%, current ratio 1.32x
  • Lower P/E (0.8x vs 10.6x)
  • 33.5% margin vs PRGO's -43.5%
Best for: valuation efficiency and defensive
PAC
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
The Growth Play

PAC ranks third and is worth considering specifically for growth exposure and long-term compounding.

  • Rev growth 21.4%, EPS growth 12.6%, 3Y rev CAGR 5.9%
  • 219.5% 10Y total return vs OMAB's 192.8%
  • Beta 0.59 vs PRGO's 1.18
Best for: growth exposure and long-term compounding
PRGO
Perrigo Company plc
The Income Pick

PRGO is the clearest fit if your priority is income & stability.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • 9.8% yield, 10-year raise streak, vs OMAB's 5.0%, (2 stocks pay no dividend)
Best for: income & stability
ASUR
Asure Software, Inc.
The Value Angle

Among these 5 stocks, ASUR doesn't own a clear edge in any measured category.

Best for: technology exposure
See the full category breakdown
CategoryWinnerWhy
GrowthLGND logoLGND27.3% revenue growth vs PRGO's -2.8%
ValueOMAB logoOMABLower P/E (0.8x vs 10.6x)
Quality / MarginsOMAB logoOMAB33.5% margin vs PRGO's -43.5%
Stability / SafetyPAC logoPACBeta 0.59 vs PRGO's 1.18
DividendsPRGO logoPRGO9.8% yield, 10-year raise streak, vs OMAB's 5.0%, (2 stocks pay no dividend)
Momentum (1Y)LGND logoLGND+99.1% vs PRGO's -51.2%
Efficiency (ROA)OMAB logoOMAB17.6% ROA vs PRGO's -19.8%, ROIC 31.7% vs 3.7%

LGND vs OMAB vs PAC vs PRGO vs ASUR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

LGNDLigand Pharmaceuticals Incorporated
FY 2024
Royalty
27.9%$109M
Intangible Royalty Assets
24.4%$95M
Royalty, Kyprolis
9.8%$38M
Material Sales, Captisol, Core
7.9%$31M
Material Sales, Captisol
7.9%$31M
Contract Revenue
7.0%$27M
Service
6.5%$26M
Other (4)
8.5%$33M
OMABGrupo Aeroportuario del Centro Norte, S.A.B. de C.V.

Segment breakdown not available.

PACGrupo Aeroportuario del Pacífico, S.A.B. de C.V.

Segment breakdown not available.

PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B
ASURAsure Software, Inc.
FY 2025
RecurringMember
90.6%$127M
ProfessionalServicesRevenueMember
9.4%$13M

LGND vs OMAB vs PAC vs PRGO vs ASUR — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPRGOLAGGINGASUR

Income & Cash Flow (Last 12 Months)

Evenly matched — LGND and OMAB each lead in 3 of 6 comparable metrics.

PAC is the larger business by revenue, generating $32.5B annually — 219.1x ASUR's $148M. OMAB is the more profitable business, keeping 33.5% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, LGND holds the edge at +122.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricLGND logoLGNDLigand Pharmaceut…OMAB logoOMABGrupo Aeroportuar…PAC logoPACGrupo Aeroportuar…PRGO logoPRGOPerrigo Company p…ASUR logoASURAsure Software, I…
RevenueTrailing 12 months$251M$16.0B$32.5B$4.2B$148M
EBITDAEarnings before interest/tax$52M$9.8B$21.3B$58M$18M
Net IncomeAfter-tax profit$49M$5.3B$10.4B-$1.8B-$10M
Free Cash FlowCash after capex$31M$5.5B$5.9B$108M$10M
Gross MarginGross profit ÷ Revenue+85.9%+75.6%+32.6%+34.2%+67.9%
Operating MarginEBIT ÷ Revenue+7.0%+56.0%+54.0%-4.1%-2.7%
Net MarginNet income ÷ Revenue+19.3%+33.5%+31.9%-43.5%-6.8%
FCF MarginFCF ÷ Revenue+12.2%+34.3%+18.0%+2.6%+6.5%
Rev. Growth (YoY)Latest quarter vs prior year+122.8%-0.0%-63.8%-7.2%+22.7%
EPS Growth (YoY)Latest quarter vs prior year+15.6%+2.6%+3.4%-56.4%+122.5%
Evenly matched — LGND and OMAB each lead in 3 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 4 of 7 comparable metrics.

At 16.7x trailing earnings, OMAB trades at a 24% valuation discount to PAC's 21.9x P/E. Adjusting for growth (PEG ratio), OMAB offers better value at 0.44x vs PAC's 0.55x — a lower PEG means you pay less per unit of expected earnings growth.

MetricLGND logoLGNDLigand Pharmaceut…OMAB logoOMABGrupo Aeroportuar…PAC logoPACGrupo Aeroportuar…PRGO logoPRGOPerrigo Company p…ASUR logoASURAsure Software, I…
Market CapShares × price$4.1B$5.2B$10.8B$1.6B$263M
Enterprise ValueMkt cap + debt − cash$4.1B$5.8B$12.9B$5.1B$318M
Trailing P/EPrice ÷ TTM EPS-956.05x16.67x21.89x-1.14x-19.13x
Forward P/EPrice ÷ next-FY EPS est.23.65x0.77x1.05x5.56x10.55x
PEG RatioP/E ÷ EPS growth rate0.44x0.55x
EV / EBITDAEnterprise value multiple322.10x10.14x10.42x7.42x16.21x
Price / SalesMarket cap ÷ Revenue24.74x5.58x5.72x0.38x1.87x
Price / BookPrice ÷ Book value/share4.63x7.79x8.81x0.55x1.27x
Price / FCFMarket cap ÷ FCF53.41x12.09x31.79x11.12x12.27x
PRGO leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — LGND and OMAB each lead in 4 of 9 comparable metrics.

OMAB delivers a 50.6% return on equity — every $100 of shareholder capital generates $51 in annual profit, vs $-51 for PRGO. LGND carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to PAC's 1.88x. On the Piotroski fundamental quality scale (0–9), PAC scores 8/9 vs ASUR's 3/9, reflecting strong financial health.

MetricLGND logoLGNDLigand Pharmaceut…OMAB logoOMABGrupo Aeroportuar…PAC logoPACGrupo Aeroportuar…PRGO logoPRGOPerrigo Company p…ASUR logoASURAsure Software, I…
ROE (TTM)Return on equity+5.1%+50.6%+41.7%-50.7%-5.1%
ROA (TTM)Return on assets+3.3%+17.6%+11.8%-19.8%-2.0%
ROICReturn on invested capital-2.3%+31.7%+21.9%+3.7%-2.8%
ROCEReturn on capital employed-2.7%+35.6%+26.5%+4.3%-3.4%
Piotroski ScoreFundamental quality 0–956843
Debt / EquityFinancial leverage0.01x1.19x1.88x1.35x0.40x
Net DebtTotal debt minus cash-$65M$10.5B$36.2B$3.4B$55M
Cash & Equiv.Liquid assets$72M$3.1B$10.5B$532M$25M
Total DebtShort + long-term debt$7M$13.6B$46.7B$4.0B$80M
Interest CoverageEBIT ÷ Interest expense22.69x6.08x5.99x-7.20x-2.02x
Evenly matched — LGND and OMAB each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LGND leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in PAC five years ago would be worth $26,620 today (with dividends reinvested), compared to $3,986 for PRGO. Over the past 12 months, LGND leads with a +99.1% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors LGND at 39.5% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricLGND logoLGNDLigand Pharmaceut…OMAB logoOMABGrupo Aeroportuar…PAC logoPACGrupo Aeroportuar…PRGO logoPRGOPerrigo Company p…ASUR logoASURAsure Software, I…
YTD ReturnYear-to-date+10.6%-1.8%-4.1%-13.5%+1.0%
1-Year ReturnPast 12 months+99.1%+16.1%+16.9%-51.2%-5.1%
3-Year ReturnCumulative with dividends+171.6%+40.1%+53.8%-58.1%-31.8%
5-Year ReturnCumulative with dividends+61.0%+157.8%+166.2%-60.1%+11.0%
10-Year ReturnCumulative with dividends+73.0%+192.8%+219.5%-77.7%+70.9%
CAGR (3Y)Annualised 3-year return+39.5%+11.9%+15.4%-25.2%-12.0%
LGND leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — LGND and PAC each lead in 1 of 2 comparable metrics.

PAC is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than PRGO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LGND currently trades 85.0% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricLGND logoLGNDLigand Pharmaceut…OMAB logoOMABGrupo Aeroportuar…PAC logoPACGrupo Aeroportuar…PRGO logoPRGOPerrigo Company p…ASUR logoASURAsure Software, I…
Beta (5Y)Sensitivity to S&P 5000.99x0.62x0.59x1.18x1.14x
52-Week HighHighest price in past year$247.38$134.99$300.41$28.44$11.48
52-Week LowLowest price in past year$98.89$89.53$206.91$9.23$6.80
% of 52W HighCurrent price vs 52-week peak+85.0%+79.3%+83.6%+41.2%+80.0%
RSI (14)Momentum oscillator 0–10059.340.549.060.946.5
Avg Volume (50D)Average daily shares traded226K92K130K3.4M103K
Evenly matched — LGND and PAC each lead in 1 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: LGND as "Buy", OMAB as "Buy", PAC as "Hold", PRGO as "Hold", ASUR as "Buy". Consensus price targets imply 70.6% upside for PRGO (target: $20) vs 3.5% for PAC (target: $260). For income investors, PRGO offers the higher dividend yield at 9.81% vs PAC's 3.89%.

MetricLGND logoLGNDLigand Pharmaceut…OMAB logoOMABGrupo Aeroportuar…PAC logoPACGrupo Aeroportuar…PRGO logoPRGOPerrigo Company p…ASUR logoASURAsure Software, I…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldHoldBuy
Price TargetConsensus 12-month target$267.75$127.00$260.00$20.00$14.75
# AnalystsCovering analysts1713153618
Dividend YieldAnnual dividend ÷ price+5.0%+3.9%+9.8%
Dividend StreakConsecutive years of raises12110
Dividend / ShareAnnual DPS$92.57$168.40$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.0%0.0%0.0%0.0%
PRGO leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

PRGO leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). LGND leads in 1 (Total Returns). 3 tied.

Best OverallPerrigo Company plc (PRGO)Leads 2 of 6 categories
Loading custom metrics...

LGND vs OMAB vs PAC vs PRGO vs ASUR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is LGND or OMAB or PAC or PRGO or ASUR a better buy right now?

For growth investors, Ligand Pharmaceuticals Incorporated (LGND) is the stronger pick with 27.

3% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Grupo Aeroportuario del Centro Norte, S. A. B. de C. V. (OMAB) offers the better valuation at 16. 7x trailing P/E (0. 8x forward), making it the more compelling value choice. Analysts rate Ligand Pharmaceuticals Incorporated (LGND) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — LGND or OMAB or PAC or PRGO or ASUR?

On trailing P/E, Grupo Aeroportuario del Centro Norte, S.

A. B. de C. V. (OMAB) is the cheapest at 16. 7x versus Grupo Aeroportuario del Pacífico, S. A. B. de C. V. at 21. 9x. On forward P/E, Grupo Aeroportuario del Centro Norte, S. A. B. de C. V. is actually cheaper at 0. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Grupo Aeroportuario del Centro Norte, S. A. B. de C. V. wins at 0. 02x versus Grupo Aeroportuario del Pacífico, S. A. B. de C. V. 's 0. 03x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — LGND or OMAB or PAC or PRGO or ASUR?

Over the past 5 years, Grupo Aeroportuario del Pacífico, S.

A. B. de C. V. (PAC) delivered a total return of +166. 2%, compared to -60. 1% for Perrigo Company plc (PRGO). Over 10 years, the gap is even starker: PAC returned +219. 5% versus PRGO's -77. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — LGND or OMAB or PAC or PRGO or ASUR?

By beta (market sensitivity over 5 years), Grupo Aeroportuario del Pacífico, S.

A. B. de C. V. (PAC) is the lower-risk stock at 0. 59β versus Perrigo Company plc's 1. 18β — meaning PRGO is approximately 100% more volatile than PAC relative to the S&P 500. On balance sheet safety, Ligand Pharmaceuticals Incorporated (LGND) carries a lower debt/equity ratio of 1% versus 188% for Grupo Aeroportuario del Pacífico, S. A. B. de C. V. — giving it more financial flexibility in a downturn.

05

Which is growing faster — LGND or OMAB or PAC or PRGO or ASUR?

By revenue growth (latest reported year), Ligand Pharmaceuticals Incorporated (LGND) is pulling ahead at 27.

3% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Grupo Aeroportuario del Pacífico, S. A. B. de C. V. grew EPS 12. 6% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ASUR leads at 13. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — LGND or OMAB or PAC or PRGO or ASUR?

Grupo Aeroportuario del Centro Norte, S.

A. B. de C. V. (OMAB) is the more profitable company, earning 33. 5% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 33. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OMAB leads at 56. 0% versus -13. 5% for LGND. At the gross margin level — before operating expenses — LGND leads at 93. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is LGND or OMAB or PAC or PRGO or ASUR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Grupo Aeroportuario del Centro Norte, S. A. B. de C. V. (OMAB) is the more undervalued stock at a PEG of 0. 02x versus Grupo Aeroportuario del Pacífico, S. A. B. de C. V. 's 0. 03x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Grupo Aeroportuario del Centro Norte, S. A. B. de C. V. (OMAB) trades at 0. 8x forward P/E versus 23. 6x for Ligand Pharmaceuticals Incorporated — 22. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 70. 6% to $20. 00.

08

Which pays a better dividend — LGND or OMAB or PAC or PRGO or ASUR?

In this comparison, PRGO (9.

8% yield), OMAB (5. 0% yield), PAC (3. 9% yield) pay a dividend. LGND, ASUR do not pay a meaningful dividend and should not be held primarily for income.

09

Is LGND or OMAB or PAC or PRGO or ASUR better for a retirement portfolio?

For long-horizon retirement investors, Grupo Aeroportuario del Pacífico, S.

A. B. de C. V. (PAC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 59), 3. 9% yield, +219. 5% 10Y return). Both have compounded well over 10 years (PAC: +219. 5%, ASUR: +70. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between LGND and OMAB and PAC and PRGO and ASUR?

These companies operate in different sectors (LGND (Healthcare) and OMAB (Industrials) and PAC (Industrials) and PRGO (Healthcare) and ASUR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: LGND is a small-cap high-growth stock; OMAB is a small-cap deep-value stock; PAC is a mid-cap high-growth stock; PRGO is a small-cap income-oriented stock; ASUR is a small-cap high-growth stock. OMAB, PAC, PRGO pay a dividend while LGND, ASUR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

LGND

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 61%
  • Net Margin > 11%
Run This Screen
Stocks Like

OMAB

Dividend Mega-Cap Quality

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 20%
  • Dividend Yield > 2.0%
Run This Screen
Stocks Like

PAC

Dividend Mega-Cap Quality

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 19%
  • Dividend Yield > 1.5%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Stocks Like

ASUR

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Gross Margin > 40%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform LGND and OMAB and PAC and PRGO and ASUR on the metrics below

Revenue Growth>
%
(LGND: 122.8% · OMAB: -0.0%)
Net Margin>
%
(LGND: 19.3% · OMAB: 33.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.